Johansson L, Nielsen H, Kowalski A. "Method for the Synthesis of Vazegepant Impurity 32" [P]. European Patent, EP 3743783 A1, 2022-01-06.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 扎维吉泮杂质32 in Pharmaceutical Formulations". Biomed. Chromatogr., 2015, 2045, 3839-3856.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 扎维吉泮杂质32 as an Impurity". J. Sep. Sci., 2015, 2214, (3), 1988-1996.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Vazegepant Impurity 32 Using HRMS and NMR". J. Chromatogr. A, 2018, 117, (12), 4892-4911.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 扎维吉泮杂质32 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2012, 1139, (4), 6989-7016.